Cited by — Clopidogrel Versus Dual‐Antiplatelet Therapy for Long‐Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT‐BIRISK Trial

Cited by — Clopidogrel Versus Dual‐Antiplatelet Therapy for Long‐Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT‐BIRISK Trial | ResearchHub - ResearchHub